JOHN HENRY SCHRANK JR. M.D.
Prescription History 1194777821
Internal Medicine - Infectious Disease in Greenville, SC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOHN HENRY SCHRANK JR. M.D., an active Infectious Disease specialist practicing in Greenville, SC. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 407 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 197 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other SC PrescribersVs. SC Avg |
|---|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 197 | $3,921.08 | ▲ More than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 197 Medicare prescriptions for Biktarvy, about 1.6 times the volume of the typical South Carolina prescriber of this medication (122.8). Medicare paid an average of $3,921.08 per fill, versus $3,874.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 199 30-Day Fills standardized to 30-day supplies 5,970 Days of Medication total across all patients in 2024 | |||
| TriumeqAbacavir/Dolutegravir/Lamivudi | 66 | $3,547.82▼ below SC avg | ▲ More than typical |
About Triumeq: This product contains 3 drugs: abacavir, dolutegravir, and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A combination of abacavir/dolutegravir/lamivudine. In 2024, this provider wrote 66 Medicare prescriptions for Triumeq, about 1.5 times the volume of the typical South Carolina prescriber of this medication (43.4). Medicare paid an average of $3,547.82 per fill, versus $3,722.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the SC average for this medication. 66 30-Day Fills standardized to 30-day supplies 1,980 Days of Medication total across all patients in 2024 | |||
| Cefadroxil | 39 | $47.26 | ≈ Typical |
About Cefadroxil: This medication is used to treat a wide variety of bacterial infections. Show more ▾ It belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative. In 2024, this provider wrote 39 Medicare prescriptions for Cefadroxil, about the same volume as the typical South Carolina prescriber of this medication (36.7). Medicare paid an average of $47.26 per fill, versus $14.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58.3 30-Day Fills standardized to 30-day supplies 1,693 Days of Medication total across all patients in 2024 | |||
| DovatoDolutegravir Sodium/Lamivudine | 34 | $2,991.96 | ▼ Less than typical |
About Dovato: This product contains 2 drugs: dolutegravir and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Lamivudine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 34 Medicare prescriptions for Dovato, about 68% of the volume of the typical South Carolina prescriber of this medication (49.6). Medicare paid an average of $2,991.96 per fill, versus $2,908.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 28 | $4,578.90 | ≈ Typical |
About Symtuza: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Darunavir is known as a protease inhibitor. Cobicistat helps darunavir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Darunavir/co-bicistat/emtricitabina/tenofovir alafenamide combination drug. In 2024, this provider wrote 28 Medicare prescriptions for Symtuza, about 89% of the volume of the typical South Carolina prescriber of this medication (31.6). Medicare paid an average of $4,578.90 per fill, versus $4,560.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| TivicayDolutegravir Sodium | 16 | $2,049.69▼ below SC avg | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. An HIV integrase inhibitor that is used in the treatment of HIV INFECTIONS in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 16 Medicare prescriptions for Tivicay, about a third of the volume of the typical South Carolina prescriber of this medication (56.4). Medicare paid an average of $2,049.69 per fill, versus $2,423.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the SC average for this medication. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 14 | $3,612.81 | ▼ Less than typical |
About Odefsey: This product contains 3 different medications: emtricitabine, rilpivirine, and tenofovir alafenamide. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine and tenofovir alafenamide belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Rilpivirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine/rilpivirine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 14 Medicare prescriptions for Odefsey, about a third of the volume of the typical South Carolina prescriber of this medication (35). Medicare paid an average of $3,612.81 per fill, versus $3,541.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Daptomycin | 13 | $826.06▼ below SC avg | ▼ Less than typical |
About Daptomycin: This medication is an antibiotic used to treat serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. Daptomycin is not recommended for use in children younger than 12 months due to possible risk of serious side effects. A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. In 2024, this provider wrote 13 Medicare prescriptions for Daptomycin, about half the volume of the typical South Carolina prescriber of this medication (27.3). Medicare paid an average of $826.06 per fill, versus $826.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average SC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the SC average for this medication. 13 30-Day Fills standardized to 30-day supplies 81 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JOHN HENRY SCHRANK JR. M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Greenville, SC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among SC prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
